Procter & Gamble (PG): Q4 2026 results, my verdict

2026-07-29 · By Lubin Danilo, founder of Lubin Investment

PG: see the full analysis on Lubin Investment

Procter & Gamble reported on July 29, 2026 revenue of $21.2 billion, with organic growth hitting zero this quarter after four years driven by price increases. My quality screen validates 8 out of 10 criteria, but my model judges the stock overvalued by roughly 53%. Here is how I separate real quality from the price to pay.

What just happened: the pricing engine stalls

Procter & Gamble reported before market open on July 29, 2026 its fiscal fourth-quarter 2026 results (period ended late June 2026): revenue of $21.2 billion, slightly below the $21.38 billion estimate, and adjusted ('core') earnings per share of $1.43, above the $1.41 consensus but down 3% year over year. GAAP earnings per share fell more sharply, down 15%, to $1.26. For the full fiscal year 2026, revenue grew 3%, but that figure hides a harsher reality: two of the three growth points came from currency effects and only one from price increases, while actual product volume sold this quarter did not move at all. CEO Shailesh Jejurikar summed up the year by pointing to a 'challenging geopolitical and economic environment.'

That last point is worth dwelling on. For several years, P&G's growth relied on a simple mechanism: regularly raising prices on its brands (Tide, Pampers, Gillette, Ariel) faster than inflation, betting on customer loyalty. This quarter, that engine fell to zero: neither volume, nor price, nor product mix contributed to organic growth. Consumers have clearly hit a limit of tolerance for repeated price hikes. Add to that some well-identified headwinds: an expected $1 billion tariff impact in 2026, and a brand-portfolio and organizational restructuring plan announced in June 2025, expected to cost between $1 and $1.6 billion pre-tax over two years to streamline costs and reinvest in growth.

Why my quality screen validates 8 out of 10 criteria

Despite this slowdown, P&G remains a very high-quality business financially: a 19.2% net margin (nearly a fifth of revenue ends up as net profit), a share count declining 1.15% per year thanks to steady buybacks, a 16.7% free cash flow margin (the share of revenue converted into real, spendable cash), margins expanding over time, and a Cash ROCE (return on capital actually reinvested in the business) of 38.0%, a high level for a consumer goods group. Its net debt would take 1.70 years of free cash flow to repay, a solid balance sheet (see my guide on debt in the Lubin method for how I judge this criterion).

One technical figure is worth explaining, since it nicely illustrates the bargaining power of a giant like P&G over its suppliers and retailers: its net cash collection cycle is negative, at -34 days. Concretely, P&G takes on average 127 days to pay its own suppliers, while holding inventory for only 66 days and collecting from its customers (mostly retailers like Walmart or Carrefour) in just 27 days. This imbalance is no accident: it is the result of considerable negotiating power over suppliers, which lets P&G have part of its working capital needs financed by its partners rather than its own cash, a privilege reserved for only the very largest players in an industry.

Two criteria still fail, and they are directly tied to this quarter's slowdown: sales growth is only 2.3% per year on average over five years, and free cash flow per share growth only 3.2% per year, both weak paces for a company that needs to justify a growth-oriented valuation. These are precisely the two criteria that put numbers behind what this quarter's news just confirmed: the pricing engine is running out of steam.

The price: expensive despite a multiple that looks reasonable

P&G trades at 24.3 times its trailing-twelve-month free cash flow, a multiple that, taken in isolation, does not look extravagant: it stays below the 25-times threshold I consider reasonable in absolute terms. But a multiple is never judged alone: it must be weighed against the growth it is supposed to compensate for. My reasonable buy-price model, which projects the actual five-year cash-per-share generation trajectory, comes out at $69.27, versus a current price of $146.10: a premium of roughly 53%.

This is the most useful lesson from this analysis: a 24-times P/FCF is not automatically cheap if the underlying cash-per-share growth is only 3.2% per year. Paying 24 years of cash for a machine that has nearly stopped accelerating means paying the price of growth that is not showing up in the numbers. P&G remains a quiet, profitable compounder, but its price still bakes in a growth dynamic that this quarter's results directly contradict.

What could derail the thesis

The most immediate risk is continued consumer resistance to price increases, which would force P&G to choose between defending margins or winning back volume, a trade-off rarely painless. Tariffs (a $1 billion expected impact in 2026) and restructuring costs (up to $1.6 billion over two years) directly weigh on near-term profit. Finally, competition from cheaper private-label brands generally intensifies when household purchasing power tightens, a structural risk for the entire branded consumer goods sector.

Procter & Gamble reported on July 29, 2026 revenue of $21.2B, with organic growth hitting zero this quarter (volume, price, and mix all at 0%), after several years driven by price increases. Adjusted earnings $1.43 (above consensus), GAAP earnings down 15% to $1.26.
My quality screen validates 8 out of 10 criteria: 19.2% net margin, 38.0% Cash ROCE, manageable debt (1.70 years of FCF). Weak points: sales growth of only 2.3%/year and FCF per share growth of 3.2%/year over 5 years, a direct reflection of the fading pricing engine.
The 24.3x P/FCF looks reasonable in absolute terms, but my model targets a $69.27 buy price against a $146.10 current price, a premium of roughly 53%: a moderate multiple can still be expensive if underlying growth slows.
$1B tariff impact expected in 2026, restructuring plan of $1 to $1.6B over two years. This is not investment advice, do your own research.

FAQ

Why did Procter & Gamble's organic growth fall to zero?

Because its main growth engine for several years, regularly raising brand prices, stalled this quarter: neither volume, price, nor product mix contributed to organic growth, a sign that consumers are now resisting repeated price hikes.

Why is Procter & Gamble's net cash collection cycle negative?

Because P&G takes on average 127 days to pay its suppliers, while collecting from its own customers in just 27 days and turning inventory in 66 days. This negotiating power over suppliers, reserved for only the largest groups, lets it have part of its cash needs financed by partners.

Is a 24-times P/FCF expensive for Procter & Gamble?

The multiple alone does not look extravagant, but it must be compared to the growth it compensates for: with free cash flow per share growing only 3.2% per year, my model judges the stock overvalued by roughly 53%. A moderate multiple can still be expensive if underlying growth slows.

Should you buy Procter & Gamble stock after these results?

The quality of the business remains real (8 out of 10 criteria), but my reasonable buy-price model targets $69.27 against a $146.10 price, a premium of roughly 53%. The slowdown of organic growth to zero this quarter makes this price even more demanding. This is not personalized investment advice, do your own research.

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).